Urea Breath Test Guidelines

Pre-Test Patient Preparation

The American Gastroenterological Association recommends stopping proton pump inhibitors (PPIs) for at least 2 weeks before testing to avoid false-negative results, as PPIs reduce bacterial load and cause 10-40% false-negative rates 1, 2
The American Gastroenterological Association suggests discontinuing antibiotics and bismuth compounds for at least 4 weeks prior to testing, as these medications temporarily suppress H. pylori and produce false-negative results 1, 2
Patients must fast for at least 6 hours before the test, as recommended by the American College of Gastroenterology 3

The European Society of Clinical Microbiology and Infectious Diseases recommends administering 75 mg of ¹³C-labeled urea with a test meal to delay gastric emptying and allow even distribution throughout the stomach 4, 5
Tablet formulations of ¹³C-urea are superior to liquid forms as they avoid interference from urease-producing bacteria in the oropharynx, according to the European Society of Clinical Microbiology and Infectious Diseases 4
Collect the second breath sample 10-30 minutes after urea ingestion, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 4, 5

The Urea Breath Test demonstrates excellent accuracy with sensitivity of 94.7-97% and specificity of 95-95.7% based on analysis of 3,643 patients, according to the American College of Gastroenterology 3, 2, 4
Positive results can be trusted even if the patient was on medications, as PPIs and antibiotics cause false-negatives, not false-positives, as stated by the American Gastroenterological Association 1
False-positive results may occur in patients with achlorhydria or atrophic gastritis due to urease-producing non-H. pylori organisms, according to the American Gastroenterological Association 1, 6

The most common cause of false-negative results is inadequate washout of PPIs, antibiotics, or bismuth, as stated by the American Gastroenterological Association 1, 2
If testing cannot be delayed, a positive result remains valid despite recent medication use, according to the American Gastroenterological Association 1
In patients with low bacterial load (premalignant or malignant gastric lesions), false-negative results are more common, and consider endoscopy with biopsies if clinical suspicion remains high despite negative UBT, as recommended by the American College of Gastroenterology 6

The urea breath test requires labeled urea substrate (¹³C-urea or ¹⁴C-urea), breath collection containers, and analytical equipment—either a mass spectrometer for ¹³C analysis or a scintillation counter for ¹⁴C analysis, with infrared spectrometry as a practical alternative for ¹³C testing 7, 8
¹³C-labeled urea (75-100 mg) is the preferred substrate, available in tablet or liquid formulation 9
¹⁴C-labeled urea (37-185 kBq) can be used but involves radiation exposure, making ¹³C the preferred choice 7, 8
Breath collection containers are necessary for capturing exhaled air samples 7, 8
For ¹⁴C testing: CO₂-trapping agent (hyamine) is used to capture exhaled breath 7, 8
Scintillation counter is used to measure radioactivity for ¹⁴C-urea testing 7, 8

A test meal may be used to delay gastric emptying and allow even distribution of labeled urea throughout the stomach, although evidence suggests its absence may not affect accuracy 7, 8, 9

The urea breath test (UBT) exploits H. pylori's abundant production of urease enzyme, and when patients ingest isotopically labeled urea, the bacterial urease hydrolyzes it into ammonia and labeled CO₂, which can be measured, with ¹³C-urea being the preferred choice over ¹⁴C-urea due to its non-radioactive nature, making it safe for children and pregnant women 10
The UBT is the gold standard for confirming successful eradication of H. pylori infection, with testing recommended 4-6 weeks after completing treatment to avoid false-negatives 10

The American Gastroenterological Association recommends that primary care physicians have access to the ¹³C-urea breath test, ideally provided as a central service to primary care practices, as it is the gold standard non-invasive test for H. pylori diagnosis 11
The ¹³C-urea breath test should be widely available to primary care practices, as it is easy to perform, does not require special transport conditions, and is available at reasonable cost, though more expensive than serology 11
For patients under 40-45 years of age with dyspeptic symptoms but without alarm symptoms, who test positive for H. pylori, treatment can be initiated by primary care physicians without endoscopy, using a "test and treat" strategy 11